Mathai Karackampoyk Mammen from Chatsworth, CA, age 85

Resumes

Mathai Mammen

View page

News

Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research

View page

hair, BIO), Fiona Marshall (President, Biomedical Research, Novartis), Marcus Schindler (CSO, Novo Nordisk), Robert Plenge (Chief Research Officer, Bristol Myers Squibb), Sally Kornbluth (President, MIT), Anne Klibanski (CEO, Mass General Brigham), John Maraganore (former CEO, Alnylam), Mathai Mammen

Date

Sep 24, 2024

Category:

Your local news

Source:

Google

Will existing COVID-19 vaccines work against the Omicron variant? CEOs and scientists weigh in

View page

Dr. Mathai Mammen, global head of research and development for the company, said Omicron's presence shows that drugmakers must continue testing and monitoring COVID-19's mutations. J&J is currently testing its vaccine against Omicron, Mammen said.

Date

Dec 07, 2021

Category:

More news

Source:

Google

UPDATE 1-COVID-19 vaccine makers start work on Omicron-tailored shots

View page

"We have begun work to design and develop a new vaccine against Omicron and will rapidly progress it into clinical studies if needed," said Mathai Mammen, global head of research for J&J's pharmaceuticals unit.

Date

Nov 29, 2021

Category:

More news

Source:

Google

NC Coronavirus update August 25: Wake County doctors to discuss community-wide hospital capacity strain Wednesday morning

View page

robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine," said Mathai Mammen, M.

Date

Aug 25, 2021

Category:

More news

Source:

Google

US pediatric COVID-19 cases now match winter surge

View page

months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine," said Mathai Mammen, MD, PhD, the global head of research and development, in a press release.

Date

Aug 25, 2021

Category:

More news

Source:

Google

Covid Live News and Updates

View page

scussing with public health officials a potential strategy for our Johnson & Johnson Covid-19 vaccine, boosting eight months or longer after the primary single-dose vaccination, Dr. Mathai Mammen, the global head of Janssen Research & Development at Johnson & Johnson, said in a statement.

Date

Aug 25, 2021

Category:

More news

Source:

Google

Johnson & Johnson says COVID-19 vaccine protects against delta variant

View page

show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time," Dr. Mathai Mammen, the global head of Johnson and Johnson's Janssen Research & Development, said in the statement.

Date

Jul 02, 2021

Category:

More news

Source:

Google

COVID-19 Vaccines Work Way Better Than We Had Ever Expected. Scientists Are Still Figuring Out Why.

View page

Scientists were still cautious early on, said Mathai Mammen, Johnson & Johnsons global head of pharmaceutical research and development, because while the repair mechanism for the coronavirus was known, the virus doesnt stay as unchanging as measles, for example, where vaccination lasts a lifet

Date

Jun 05, 2021

Category:

More news

Source:

Google

Videos & Images